CD44 and cancer: In this section, we discuss the fate of prognosis of TNBC in parallel to the presence of CD44+/CD24- and ALDH breast stem cell marker expression, the presence of metastatic regional lymph node and distant metastasis along with the heterogeneity in the cancer cell population, and contrasting results regarding CD44+/CD24-.